BD Ultra-Fine Insulin Syringes Recall: Nonsterile Risk of Infection
Becton Dickinson recalls BD Ultra-Fine Insulin Syringes (0.5mL, 8mm, 31G) due to nonsterile condition potentially causing infections. Affected lots expire by 2027.
Lower-risk recall
Nonsterile syringe potentially exposing the patient to pathogenic microorganisms and a risk of local infection.
Contact the company
What happened, in plain English
Becton Dickinson is recalling insulin syringes that may not be sterile, increasing infection risk. This affects people using insulin for diabetes who own the specific lots listed. Read more at govinfonow.com/recall/58970-bd-ultra-fine-insulin-syringes-recall-nonsterile-risk-of-infection.
Source Summary by GovInfoNow · govinfonow.com/recall/58970-bd-ultra-fine-insulin-syringes-recall-nonsterile-risk-of-infection · Updated August 19, 2026 · FDA enforcement record: FDA #Z-1240-2023
Cite this page
“BD Ultra-Fine Insulin Syringes Recall: Nonsterile Risk of Infection.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/58970-bd-ultra-fine-insulin-syringes-recall-nonsterile-risk-of-infection. Based on FDA recall #Z-1240-2023 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1240-2023%22&limit=1).
Why it’s dangerous
The syringes may not be sterile, which can expose patients to harmful bacteria. This could lead to infections at the injection site, especially in people with diabetes who need frequent injections.
Who’s affected
People using insulin for diabetes who own the recalled syringes (0.5mL, 8mm, 31G) are affected. Those with diabetes who use these syringes are at higher risk of infection.
How to tell if you have this one
Check for the lot numbers: 2038580 (expiring May 2027), 2063298 (expiring May 2027), or 2137904 (expiring July 2027). The syringes are 0.5mL, 8mm, 31G for insulin use.
- Brand
Becton Dickinson- Category
Medical device
All 8 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Ongoing- Distribution
Worldwide distribution - US Nationwide and the countries of Chile, Colombia, Dominican Republic, Bahamas, Panama, Peru, Mexico, El Salvador, Mexico, Malaysia, Philippines, Vietnam, Hong Kong, Taiwan, Thailand, Canada.
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| Z-1237-2023 | BD Ultra-Fine Insulin Syringe 0.5mL, 6mm, 31G - Insulin Syringes are designed for administering insulin in the treatment of diabetes mellitus. Catalog Number: 326679; UDI_DI: N/A Lot Number: 2164338 Exp Date: 20270831 | 45, 000 units |
| Z-1238-2023 | BD Insulin Syringes with the BD Micro-Fine TM IV Needle 1ml, 12.7mm, 28G Single Unit Scale. Insulin Syringes are designed for administering insulin in the treatment of diabetes mellitus. Catalog Number: 329420; GTIN: (01) 00382903294206 Lot Number: 2038204 Exp. Date: 20270430 | 961,000 units |
| Z-1239-2023 | BD Insulin Syringes with the BD Micro-Fine IV Needle 1 ml, 12. 7mm, 28G Two Unit Scale- Insulin Syringes are designed for administering insulin in the treatment of diabetes mellitus. Catalog Number: 329424; GTIN : (01) 00382903294244 Lot Number: 2024074 Exp. Date: 2024074; Lot Number: 2045195 Exp. Date: 20270430 | 1,921,000 units |
| Z-1240-2023 | BD Ultra-Fine Insulin Syringe 0.5mL, 8mm, 31G-Insulin Syringes are designed for administering insulin in the treatment of diabetes mellitus. Catalog Number: 326713; GTIN: N/A Lot Number: 2038580, Exp. Date: 20270531; Lot Number: 2063298, Exp. Date: 20270531; Lot Number: 2137904, Exp. Date: 20270731 | 1,129,000 units |
| Z-1241-2023 | BD Ultra-Fine Insulin Syringe 1mL, 6mm, 31G-Insulin Syringes are designed for administering insulin in the treatment of diabetes mellitus. Catalog Number: 326678; GTIN: N/A Lot Number: 2045201, Exp. Date: 20270430; Lot Number: 2073801, Exp. Date: 20270531 | 1,168,000 units |
| Z-1242-2023 | BD Insulin Syringes with the BD Micro-Fine IV Needle 0.5ml, 12.7mm, 28G Single Unit Scale-Insulin Syringes are designed for administering insulin in the treatment of diabetes mellitus. Catalog Number: 329461; GTIN: (01) 00382903294619 Lot Number: 2031528, Exp. Date: 20270430 | 686,500 units |
| Z-1243-2023 | BD Ultra-Fine Insulin Syringe 1mL, 12.7mm, 29G-Insulin Syringes are designed for administering insulin in the treatment of diabetes mellitus. Catalog Number: 326719; GTIN: N/A Lot Number: 2031581, Exp. Date: 2031581 | 80,500 units |
| Z-1244-2023 | BD Ultra-Fine II Insulin Syringe 0.5mL, 8mm, 30G-Insulin Syringes are designed for administering insulin in the treatment of diabetes mellitus. Catalog Number: 326725; GTIN: N/A Lot Number: 2010670, Exp. Date:2031581 Lot Number: 2052365, Exp. Date:20270531 | 1,472,400 units |
What to do — step by step
Check Syringe Lot Number
Look for lot numbers 2038580, 2063298, or 2137904 on the syringe packaging.
Where it went and when
Where it was distributed
Distributed nationwide, and outside the U.S.
FDA distribution: “Worldwide distribution - US Nationwide and the countries of Chile, Colombia, Dominican Republic, Bahamas, Panama, Peru, Mexico, El Salvador, Mexico, Malaysia, Philippines, Vietnam, Hong Kong, Taiwan, Thailand, Canada.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide, and outside the U.S.
Recall timeline
FDA published this recall 49 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest medical device recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #Z-1240-2023 (February 1, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1240-2023 to see it in context.
- Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.